secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001104659-23-088428
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed Q2 revenue $348.2M (+29% YoY); adj. EBITDA $35.8M (+44%); reaffirms FY23 guidance
--------------------------------------------------------------------------------

- Revenue $348.2M (+29% YoY); Care Partners revenue $325.2M (+32%); net income $13.2M (+10%).
- Adjusted EBITDA $35.8M (+44% YoY); reaffirms FY23 guidance: revenue $1.3-1.5B, Adj. EBITDA $120-160M.
- Recent deals: entered agreement to acquire Texas Independent Providers (120+ PCPs); formed partnership with IntraCare (425+ providers) with $25M convertible note.
- Tax restatement for 2020-2022 related to intercompany dividends; no impact on revenue, EBITDA, or past/forward periods.
- Cash and investments $297.7M; total stockholders' equity $566M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465923088428/0001104659-23-088428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465923088428/tm2323017d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-088428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer